The Current State of Donor-Derived Cell-Free DNA Use in Allograft Monitoring in Kidney Transplantation

The Current State of Donor-Derived Cell-Free DNA Use in Allograft Monitoring in Kidney Transplantation

Renal transplantation is the definitive therapy for patients suffering from end-stage renal disease. Though there have been significant advances in immunosuppression in these patients, there is still up to 30% acute and subclinical rejection. Current standards employ lab markers of renal function an...

Full description

Bibliographic Details
Main Authors: Michael L. Kueht, Laxmi Priya Dongur, Matthew Cusick, Heather L. Stevenson, Muhammad Mujtaba
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Journal of Personalized Medicine
Subjects:
renal transplantation
T-cell mediated rejection
antibody-mediated rejection
do-nor-derived cell-free DNA
Online Access:https://www.mdpi.com/2075-4426/12/10/1700

Similar Items

Similar Items